FDA Adverse Event Malfunction Summary report: N

THERAKOS CELLEX PHOTOPHERESIS SYSTEM

MDR report key: 3834613 · Received March 19, 2014

Report

Report Number
2523595-2014-00083
Event Type
Malfunction
Date Received
March 19, 2014
Date of Event
February 21, 2014
Report Date
February 21, 2014
Manufacturer
THERAKOS INC
Product Code
LNR
PMA / PMN Number
P980003
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF LOT FILE B335 WAS PERFORMED. THERE WERE NO NONCONFORMANCES ASSOCIATED WITH THIS EVENT TYPE REPORTED FOR THIS LOT NUMBER. THIS LOT MET ALL RELEASE REQUIREMENTS. TRENDS HAVE BEEN RECEIVED FOR THIS COMPLAINT CATEGORY AND NO TREND HAS BEEN DETECTED. SRV#(B)(4) SERVICE ORDER FEEDBACK: FIELD ENGINEER PERFORMED SYSTEM CHECKOUT PROCEDURE, RECALIBRATED PRESSURE TRANSDUCER AND DOUBLE CHECKED TRANSDUCER PER CALIBRATION. THE ASSESSMENT IS BASED ON INFORMATION AVAILABLE AT THE TIME OF THE INVESTIGATION. NO PRODUCT WAS RETURNED BY THE CUSTOMER. THEREFORE, THE ROOT CAUSE FOR THE LEAK CANNOT BE DETERMINED BASED SOLELY ON THE INFORMATION PROVIDED BY THE CUSTOMER. CAPA (B)(4) HAVE BEEN INITIATED TO INVESTIGATE CELLEX PRESSURE DOME LEAKS. (B)(4).

Description of Event or Problem · 1

CUSTOMER IS REPORTING A PRESSURE DOME LEAK. NAME AND FUNCTION OF COMPLAINANT: SAME AS REPORTER CUSTOMER CALLED TO REPORT SYSTEM PRESSURE ALARMS X3 FOLLOWED BY A BLOOD LEAK AT THE SYSTEM PRESSURE DOME AFTER 231ML WHOLE BLOOD PROCESSED. TREATMENT WAS ABORTED. CUSTOMER CHOSE TO RETURN THE BLOOD FROM THE RETURN BAG TO THE PT MANUALLY AND START ANOTHER TREATMENT. NO FURTHER TESTS OR INTERVENTIONS WILL BE DONE. PT IS STABLE. SERVICE ORDER SRV# (B)(4) WAS DISPATCHED FOR INSPECTION OF THE INSTRUMENT. CUSTOMER DID NOT RETURN ANY PRODUCT FOR INVESTIGATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
162645 THERAKOS CELLEX PHOTOPHERESIS SYSTEM CELLEX SCP SYSTEM LNR THERAKOS INC 6661 B335-KIT

Patients

Seq Age Sex Outcome Treatment
1 44 YR